Coombes Rebecca
BMJ. 2007 Feb 10;334(7588):290-1. doi: 10.1136/bmj.39119.546181.59.
Criticised for being too close to the drug industry, the US drug regulator is trying to fix its image as the guardian of drug safety
因被指责与制药行业关系过于密切,美国药品监管机构正试图重塑其作为药品安全守护者的形象。